Translational Development Acquisition Corp.

TDAC | NASDAQ

$10.87

$0 (0.00%)

Sep 22, 2026, 12:49 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022
PE Ratio	28.35	-617.90	-83.42	-575.29
PEG Ratio	-0.01	7.14	-0.14	n/a
PS Ratio	n/a	38.04	n/a	n/a
PB Ratio	1.03	0.24	-79.86	-1.83K
P/FCF Ratio	-297.43	-47.61	-198.73K	-279.59K
P/OCF Ratio	-297.43	-47.61	-198.73K	-279.59K
OCF/S Ratio	n/a	-79.89	n/a	n/a
Debt / Equity Ratio	0	36.21K	-0.68	-11.72
Quick Ratio	0.07	3.09	0	0.12
Current Ratio	0.07	3.09	0	0.12
Asset Turnover	n/a	0.01	n/a	n/a
Interest Coverage	n/a	-0.39	n/a	n/a
Return on Equity	3.63%	-0.04%	95.65%	319.62%
Return on Assets	3.50%	-0.04%	-24.03K%	-16.16%
Return on Invested Capital	-0.52%	n/a	303.17%	-29.84%
Dividend Yield	n/a	0.31%	n/a	n/a
Payout Ratio	n/a	-176.51%	n/a	n/a
FCF Payout Ratio	n/a	-14.72%	n/a	n/a
Gross Profit Margin	n/a	69.89%	n/a	n/a
Net Profit Margin	n/a	-6.66%	n/a	n/a
Pretax Profit Margin	n/a	-6.66%	n/a	n/a
Operating Profit Margin	n/a	-18.42%	n/a	n/a
FCF Margin	n/a	-79.89%	n/a	n/a
EBITDA Margin	n/a	-6.66%	n/a	n/a